Lenalidomide

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Lenalidomide and local guidelines before prescribing.

Immunomodulator

Mechanism

Immunomodulator derived from thalidomide.

Uses

Multiple myeloma, myelodysplastic syndromes with 5q deletion.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Myelosuppression, VTE, diarrhoea, fatigue, rash, teratogenicity.

Interactions

Digoxin levels increase; ESAs increase VTE risk.

Contraindications and cautions

Pregnancy

Monitoring

FBC, TFT, renal function

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Reduce dose in renal impairment

Overdose and reversal

Supportive

Special advice

Pregnancy prevention programme; thromboprophylaxis; FBC weekly initially.

More from the textbook: uses, cautions and other points
Where it is discussed in the book